Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30021565HIVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20000255HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20006006HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20046447HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20057837HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20057381HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20067624HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20057499HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20044124HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20036122HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TCGA Plot Options
Drug Information
GeneCACNA1D
DrugBank IDDB04920
Drug NameClevidipine
Target IDBE0002359
UniProt IDQ01668
Regulation Type
PubMed IDs15492770
CitationsNordlander M, Sjoquist PO, Ericsson H, Ryden L: Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev. 2004 Fall;22(3):227-50.
GroupsApproved; Investigational
Direct ClassificationDihydropyridinecarboxylic acids and derivatives
SMILESCCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
Pathways
PharmGKB
ChEMBLCHEMBL1237132